Literature DB >> 12064182

Use of opioids for pain and anesthetic management in horses.

Rachel C Bennett1, Eugene P Steffey.   

Abstract

REGIONAL ADMINISTRATION: There is limited, but convincing, evidence that epidural administration of morphine and some other mu-agonist opioids consistently relieves regional pain in horses. In addition, this effect is not accompanied by notable undesirable effects. On the other hand, a clinically important analgesic action has not been demonstrated for similarly administered kappa-agonist opioids. There has been little objective data presented to support the analgesic effectiveness of intra-articularly administered opioids in horses. However, the evidence of local opioid receptors legitimately encourages work to substantiate the value of intra-articular opioid administration to relieve joint-associated pain in horses. SYSTEMIC ADMINISTRATION: So far, study results do not provide convincing, objective evidence to support the opinion that systemically administered opioids consistently and effectively relieve pain in horses. Given this lack of evidence, and considering that opioids stimulate locomotor and other forms of unwanted excitant behavior, reduce propulsive gastrointestinal motility, decrease alveolar ventilation (especially in association with general anesthesia), and require regulatory and practical considerations for abuse potential in both humans and horses, we conclude that routine, indiscriminate administration of opioids for pain relief in horses is not justified. Identification and focused, objective study of selective beneficial opioid actions to provide guidance for appropriate clinical use is long overdue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064182     DOI: 10.1016/s0749-0739(02)00011-1

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  5 in total

1.  Epidural analgesia with morphine or buprenorphine in ponies with lipopolysaccharide (LPS)-induced carpal synovitis.

Authors:  Gabrielle C Freitas; Adriano B Carregaro; Martielo I Gehrcke; Flávio D De La Côrte; Valéria M Lara; Ricardo Pozzobon; Karin E Brass
Journal:  Can J Vet Res       Date:  2011-04       Impact factor: 1.310

2.  Preliminary study of the pharmacokinetics, tissue distribution, and behavioral and select physiological effects of morphine 6-glucuronide (M6G) following intravenous administration to horses.

Authors:  Briana D Hamamoto-Hardman; Eugene P Steffey; Kelsey Seminoff; Daniel S McKemie; Philip Kass; Heather K Knych
Journal:  Can J Vet Res       Date:  2022-07       Impact factor: 0.897

3.  Morphine with or without Acepromazine in Horses: A Kinematic Evaluation.

Authors:  F Javier López-Sanromán; G Montes Freilich; D Gómez-Cisneros; J Izquierdo-Moreno; M Varela Del Arco; G Manso-Díaz
Journal:  Animals (Basel)       Date:  2022-05-06       Impact factor: 3.231

4.  Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses.

Authors:  Briana D Hamamoto-Hardman; Eugene P Steffey; Daniel S McKemie; Philip H Kass; Heather K Knych
Journal:  BMC Vet Res       Date:  2020-10-01       Impact factor: 2.741

5.  A multicentre, prospective, randomised, blinded clinical trial to compare some perioperative effects of buprenorphine or butorphanol premedication before equine elective general anaesthesia and surgery.

Authors:  P M Taylor; H R Hoare; A de Vries; E J Love; K M Coumbe; K L White; J C Murrell
Journal:  Equine Vet J       Date:  2015-06-10       Impact factor: 2.888

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.